375 related articles for article (PubMed ID: 33845381)
21. Synthesis of new isoquinoline-base-oxadiazole derivatives as potent inhibitors of thymidine phosphorylase and molecular docking study.
Zaman K; Rahim F; Taha M; Wadood A; Shah SAA; Ahmed QU; Zakaria ZA
Sci Rep; 2019 Nov; 9(1):16015. PubMed ID: 31690793
[TBL] [Abstract][Full Text] [Related]
22. Acridone-pyrimidine hybrids- design, synthesis, cytotoxicity studies in resistant and sensitive cancer cells and molecular docking studies.
Murahari M; Prakash KV; Peters GJ; Mayur YC
Eur J Med Chem; 2017 Oct; 139():961-981. PubMed ID: 28886509
[TBL] [Abstract][Full Text] [Related]
23. Exploring the newer oxadiazoles as real inhibitors of human SIRT2 in hepatocellular cancer cells.
Dukanya ; Shanmugam MK; Rangappa S; Metri PK; Mohan S; Basappa ; Rangappa KS
Bioorg Med Chem Lett; 2020 Aug; 30(16):127330. PubMed ID: 32631535
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, biological evaluation, and molecular docking studies of 1,3,4-oxadiazole derivatives possessing 1,4-benzodioxan moiety as potential anticancer agents.
Zhang XM; Qiu M; Sun J; Zhang YB; Yang YS; Wang XL; Tang JF; Zhu HL
Bioorg Med Chem; 2011 Nov; 19(21):6518-24. PubMed ID: 21962523
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis and
Alzhrani ZMM; Alam MM; Neamatallah T; Nazreen S
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1116-1123. PubMed ID: 32354237
[TBL] [Abstract][Full Text] [Related]
26. Design, synthesis and in vitro anticancer activity of novel quinoline and oxadiazole derivatives of ursolic acid.
Gu W; Jin XY; Li DD; Wang SF; Tao XB; Chen H
Bioorg Med Chem Lett; 2017 Sep; 27(17):4128-4132. PubMed ID: 28733083
[TBL] [Abstract][Full Text] [Related]
27. Identification of 1,2,4-triazoles as new thymidine phosphorylase inhibitors: Future anti-tumor drugs.
Shahzad SA; Yar M; Khan ZA; Shahzadi L; Naqvi SAR; Mahmood A; Ullah S; Shaikh AJ; Sherazi TA; Bale AT; Kukułowicz J; Bajda M
Bioorg Chem; 2019 Apr; 85():209-220. PubMed ID: 30634096
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis, in silico and biological evaluation of new indole based oxadiazole derivatives targeting estrogen receptor alpha.
Kaur K; Verma H; Gangwar P; Jangid K; Dhiman M; Kumar V; Jaitak V
Bioorg Chem; 2024 Jun; 147():107341. PubMed ID: 38593531
[TBL] [Abstract][Full Text] [Related]
29. New indenopyrazole linked oxadiazole conjugates as anti-pancreatic cancer agents: Design, synthesis, in silico studies including 3D-QSAR analysis.
Khan I; Ganapathi T; Rehman MM; Shareef MA; Kumar CG; Kamal A
Bioorg Med Chem Lett; 2021 Jul; 44():128094. PubMed ID: 33964437
[TBL] [Abstract][Full Text] [Related]
30. New oxadiazoles with selective-COX-2 and EGFR dual inhibitory activity: Design, synthesis, cytotoxicity evaluation and in silico studies.
El-Sayed NA; Nour MS; Salem MA; Arafa RK
Eur J Med Chem; 2019 Dec; 183():111693. PubMed ID: 31539778
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of Thymidine Phosphorylase Inhibitor Based on Quinoxaline Derivatives and Their Molecular Docking Study.
Almandil NB; Taha M; Farooq RK; Alhibshi A; Ibrahim M; Anouar EH; Gollapalli M; Rahim F; Nawaz M; Shah SAA; Ahmed QU; Zakaria ZA
Molecules; 2019 Mar; 24(6):. PubMed ID: 30871147
[TBL] [Abstract][Full Text] [Related]
32. 1,3,4-oxadiazole-2-thione Derivatives; Novel Approach for Anticancer and Tubulin Polymerization Inhibitory Activities.
Abdel-Aziz M; Metwally KA; Gamal-Eldeen AM; Aly OM
Anticancer Agents Med Chem; 2015; 16(2):269-77. PubMed ID: 26343141
[TBL] [Abstract][Full Text] [Related]
33. Design and synthesis of novel HDAC8 inhibitory 2,5-disubstituted-1,3,4-oxadiazoles containing glycine and alanine hybrids with anti cancer activity.
Pidugu VR; Yarla NS; Pedada SR; Kalle AM; Satya AK
Bioorg Med Chem; 2016 Nov; 24(21):5611-5617. PubMed ID: 27665180
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of indole based acetohydrazide analogs: Their in vitro and in silico thymidine phosphorylase studies.
Taha M; Aldhamin EAJ; Almandil NB; Anouar EH; Uddin N; Alomari M; Rahim F; Adalat B; Ibrahim M; Nawaz F; Iqbal N; Alghanem B; Altolayyan A; Khan KM
Bioorg Chem; 2020 May; 98():103745. PubMed ID: 32200327
[TBL] [Abstract][Full Text] [Related]
35. Discovery of mixed type thymidine phosphorylase inhibitors endowed with antiangiogenic properties: synthesis, pharmacological evaluation and molecular docking study of 2-thioxo-pyrazolo[1,5-a][1,3,5]triazin-4-ones. Part II.
Bera H; Ojha Pk; Tan BJ; Sun L; Dolzhenko AV; Chui WK; Chiu GN
Eur J Med Chem; 2014 May; 78():294-303. PubMed ID: 24686016
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, molecular docking study and thymidine phosphorylase inhibitory activity of 3-formylcoumarin derivatives.
Taha M; Adnan Ali Shah S; Afifi M; Imran S; Sultan S; Rahim F; Hadiani Ismail N; Mohammed Khan K
Bioorg Chem; 2018 Aug; 78():17-23. PubMed ID: 29525348
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of pyrazole acrylic acid based oxadiazole and amide derivatives as antimalarial and anticancer agents.
Verma G; Chashoo G; Ali A; Khan MF; Akhtar W; Ali I; Akhtar M; Alam MM; Shaquiquzzaman M
Bioorg Chem; 2018 Apr; 77():106-124. PubMed ID: 29353728
[TBL] [Abstract][Full Text] [Related]
38. Design and synthesis of newer 1,3,4-oxadiazole and 1,2,4-triazole based Topsentin analogues as anti-proliferative agent targeting tubulin.
Naaz F; Ahmad F; Lone BA; Pokharel YR; Fuloria NK; Fuloria S; Ravichandran M; Pattabhiraman L; Shafi S; Shahar Yar M
Bioorg Chem; 2020 Jan; 95():103519. PubMed ID: 31884140
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and antitumor activity of 1,3,4-oxadiazole possessing 1,4-benzodioxan moiety as a novel class of potent methionine aminopeptidase type II inhibitors.
Sun J; Li MH; Qian SS; Guo FJ; Dang XF; Wang XM; Xue YR; Zhu HL
Bioorg Med Chem Lett; 2013 May; 23(10):2876-9. PubMed ID: 23582273
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and molecular docking study of piperazine derivatives as potent inhibitor of thymidine phosphorylase.
Uddin I; Taha M; Rahim F; Wadood A
Bioorg Chem; 2018 Aug; 78():324-331. PubMed ID: 29626638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
